Arjo AB (publ) - Asset Resilience Ratio

Latest as of March 2025: 0.18%

Arjo AB (publ) (ARJO-B) has an Asset Resilience Ratio of 0.18% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ARJO-B liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

Skr28.00 Million
≈ $3.01 Million USD Cash + Short-term Investments

Total Assets

Skr15.31 Billion
≈ $1.65 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2023)

This chart shows how Arjo AB (publ)'s Asset Resilience Ratio has changed over time. See shareholders equity of Arjo AB (publ) for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Arjo AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Arjo AB (publ) (ARJO-B) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr28.00 Million 0.18%
Total Liquid Assets Skr28.00 Million 0.18%

Asset Resilience Insights

  • Limited Liquidity: Arjo AB (publ) maintains only 0.18% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Arjo AB (publ) Industry Peers by Asset Resilience Ratio

Compare Arjo AB (publ)'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
Medical Distribution 5.56%

Annual Asset Resilience Ratio for Arjo AB (publ) (2013–2023)

The table below shows the annual Asset Resilience Ratio data for Arjo AB (publ).

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.47% Skr76.00 Million
≈ $8.18 Million
Skr16.00 Billion
≈ $1.72 Billion
-3.73pp
2022-12-31 4.20% Skr679.00 Million
≈ $73.07 Million
Skr16.17 Billion
≈ $1.74 Billion
+1.00pp
2021-12-31 3.20% Skr468.00 Million
≈ $50.36 Million
Skr14.61 Billion
≈ $1.57 Billion
-3.41pp
2020-12-31 6.62% Skr917.00 Million
≈ $98.68 Million
Skr13.86 Billion
≈ $1.49 Billion
+2.35pp
2019-12-31 4.27% Skr616.00 Million
≈ $66.29 Million
Skr14.42 Billion
≈ $1.55 Billion
-3.16pp
2018-12-31 7.43% Skr976.00 Million
≈ $105.03 Million
Skr13.14 Billion
≈ $1.41 Billion
+1.64pp
2017-12-31 5.79% Skr707.00 Million
≈ $76.08 Million
Skr12.21 Billion
≈ $1.31 Billion
-4.83pp
2016-12-31 10.62% Skr1.56 Billion
≈ $168.10 Million
Skr14.71 Billion
≈ $1.58 Billion
+10.22pp
2015-12-31 0.39% Skr55.00 Million
≈ $5.92 Million
Skr14.02 Billion
≈ $1.51 Billion
+0.07pp
2014-12-31 0.32% Skr48.00 Million
≈ $5.17 Million
Skr14.82 Billion
≈ $1.60 Billion
-0.29pp
2013-12-31 0.61% Skr81.00 Million
≈ $8.72 Million
Skr13.22 Billion
≈ $1.42 Billion
--
pp = percentage points

About Arjo AB (publ)

ST:ARJO-B Sweden Medical Distribution
Market Cap
$662.98 Million
Skr6.16 Billion SEK
Market Cap Rank
#11103 Global
#174 in Sweden
Share Price
Skr24.24
Change (1 day)
-0.66%
52-Week Range
Skr24.24 - Skr35.78
All Time High
Skr121.97
About

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and pr… Read more